HeartSciences Inc.

HSCS Healthcare Medical Devices

HeartSciences Inc.’s revenue for fiscal 2026 (year ended April 2026) was $4,300.00, down 2.27% from fiscal 2025. In the quarter to July 2026, revenue fell 46.2%, EPS grew 45.6% and free cash flow grew 18.2%, each against the same quarter a year earlier.

3.02 0.16 −5.03%
Market cap
$15.4M
P/E
0.0×
Fwd P/E
−0.6×
Dividend yield
—
F-score
4/9
Altman Z
−27.87
Beneish M
n/a
Dividend safety
n/a
Older periods Oct '25 Jan '26 Apr '26 Jul '26
ROE

+8 more TTM periods

(220.46%) (382.44%) (4,252.05%) (1,854.69%)
ROA
(131.22%) (128.00%) (192.75%) (201.67%)
ROIC
(230.90%) 0.00% 0.00% 0.00%
Return on Tangible Assets
(396.32%) (968.64%) 408.32% 214.26%
Average Days of Receivables
0.00 — — 0.00
Free Cash Flow per Share
(2.71) (2.34) (2.85) (1.94)
Free Cash Flow
(7.54) (7.39) (7.47) (7.12)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 1 Oct 2026